NIH SPECIAL Science SERIES: Cancer Vaccine – Unique Tumor-Associated Antigen to Allow the Body to Kill the Cancer - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Advertise
    • Contact
    • Editorial Staff
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
February 1, 2017 Newswires
Share
Share
Tweet
Email

NIH SPECIAL Science SERIES: Cancer Vaccine – Unique Tumor-Associated Antigen to Allow the Body to Kill the Cancer

PR Web

Boston, MA (PRWEB) January 31, 2017

One Million Solutions in Health works with the NIH through a one-of-a-kind partnership to bring science forward. Many technologies have been available for licensing or collaboration agreements. However, to accelerate a cure for cancer, this information is being shared via a webinar regarding a "Cancer Vaccine with a Unique Tumor-Associated Antigen". This science has been patented after being created by Dr. Bira Arya, Senior Investigator, National Institute on Aging – IRP.

This presentation features an exceptional discovery in the search for unique cancer antigens. It is a cancer vaccine with unique tumor-associated antigens. NIH scientists have isolated a tumor-associated antigen (TAA) that is widely expressed in various human tumors, so this sets the stage for a cancer vaccine solution.

A new patent was recently issued on this technology. And, importantly, this TAA contains a number of immune dominant regions/epitopes that are readily recognized by human T cells. It has been shown that humans can efficiently elicit specific helper and cytolytic T cells capable of killing human tumors.

> This antigen is over-expressed in metastatic cancers
> Human T cells elicit responses to this antigen and kill the tumor's expression of this antigen
> This has the potential to allow your own body to mount an attack against your own tumor to kill it

The focus is to understand how immune cells control diseases like cancer, and how we can use this knowledge to develop potent therapeutic formulations to combat cancer.

Cancer strategies often don't cure patients, and patients often relapse. To illicit long-lasting, disease-free survival, current thinking suggests the need to induce immune responses against cancer.

To do this, a number of strategies can be utilized under the auspices of cancer immunotherapy. In considering a cancer vaccine, in order to be effective, it needs to have a unique target, against which immune cells will be responding.

Review the webinar here: "Cancer Vaccine with a Unique Tumor-Associated Antigen".

ABOUT ONE MILLION SOLUTIONS IN HEALTH:

As a not-for-profit, the goal of One Million Solutions in Health™ is to shape health care by sharing solutions and, importantly, to accelerate the discovery, development and delivery ... of innovative cures, treatments and preventative measures for patients around the world. By facilitating efforts to ensure organizations can Connect, Learn + Share, Innovate and Collaborate, our vision is to improve health care delivery, accelerate life sciences research and share patient and consumer-focused ideas and solutions.

By engaging scientists, entrepreneurs, investors, innovators, industry experts, health care professionals, and patients across various disciplines, and from around the world, we can utilize the power of the internet to disrupt things in a positive and transformative way to accelerate the movement of new solutions and scientific discoveries from the scientist to the patient.

The Technology Evaluation Consortium (TEC) brings together life sciences and/or health care companies and technology providers, and other relevant partners (e.g., government and Universities) to evaluate and validate technologies or services in a collaborative environment. The model empowers technology providers and industry end users to collectively assess a number of technologies in a cost-effective manner, producing a depth and breadth of results that no company can achieve alone.

We are on our way towards accelerating high-potential innovations, catalyzing investment and increasing awareness of, and support for, important ideas to improve health and save lives. We are thrilled to have you be a part of this transformative journey!

IF YOU HAVE A TECHNOLOGY, SCIENTIFIC DISCOVERY OR MEDICAL SOLUTION YOU WOULD LIKE US TO HELP SHARE WITH THE WORLD, CONTACT US.

For more information: http://www.onemillionsolutionsinhealth.org

CONTACT:

One Million Solutions in Health™
Dawn Van Dam
Executive Director & CEO
Email: dawn.vandam(at)onemillionsolutionsinhealth(dot)org
Phone: 416-402-8274
Twitter: @DawnVanDam

Read the full story at http://www.prweb.com/releases/2017/02/prweb14033203.htm

Older

Gorsuch: Conservative court nominee praised by some liberals

Newer

GBI investigating Muscogee County School District’s lawsuit settlement

Advisor News

  • Affordability on Florida lawmakers’ minds as they return to the state Capitol
  • Gen X confident in investment decisions, despite having no plan
  • Most Americans optimistic about a financial ‘resolution rebound’ in 2026
  • Mitigating recession-based client anxiety
  • Terri Kallsen begins board chair role at CFP Board
More Advisor News

Annuity News

  • Reframing lifetime income as an essential part of retirement planning
  • Integrity adds further scale with blockbuster acquisition of AIMCOR
  • MetLife Declares First Quarter 2026 Common Stock Dividend
  • Using annuities as a legacy tool: The ROP feature
  • Jackson Financial Inc. and TPG Inc. Announce Long-Term Strategic Partnership
More Annuity News

Health/Employee Benefits News

  • TRUMP ADMINISTRATION DROPS MEDICAID VACCINE REPORTING REQUIREMENTS
  • SLOTKIN, WHITEHOUSE, AND SCHAKOWSKY INTRODUCE PUBLIC HEALTH INSURANCE OPTION LEGISLATION
  • Wittman, Kiggans split on subsidies Wittman, Kiggans split on subsidies
  • Wittman, Kiggans split on subsidies Va. Republicans split over extending health care subsidies
  • Report: Connecticut can offset nearly $1B in federal cuts
More Health/Employee Benefits News

Life Insurance News

  • Best's Review Looks at What’s Next in 2026
  • Life insurance application activity ends 2025 with record growth, MIB reports
  • Vermont judge sides with National Life on IUL illustrations lawsuit
  • AM Best Affirms Credit Ratings of Insignia Life S.A. de C.V.
  • Whole life or IUL? Help clients to choose what’s best for them
Sponsor
More Life Insurance News

- Presented By -

Top Read Stories

More Top Read Stories >

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Elevate Your Practice with Pacific Life
Taking your business to the next level is easier when you have experienced support.

ICMG 2026: 3 Days to Transform Your Business
Speed Networking, deal-making, and insights that spark real growth — all in Miami.

Your trusted annuity partner.
Knighthead Life provides dependable annuities that help your clients retire with confidence.

8.25% Cap Guaranteed for the Full Term
Guaranteed cap rate for 5 & 7 years—no annual resets. Explore Oceanview CapLock FIA.

Press Releases

  • Two industry finance experts join National Life Group amid accelerated growth
  • National Life Group Announces Leadership Transition at Equity Services, Inc.
  • SandStone Insurance Partners Welcomes Industry Veteran, Rhonda Waskie, as Senior Account Executive
  • Springline Advisory Announces Partnership With Software And Consulting Firm Actuarial Resources Corporation
  • Insuraviews Closes New Funding Round Led by Idea Fund to Scale Market Intelligence Platform
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Advertise
  • Contact
  • Editorial Staff
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.
Insurance News | InsuranceNewsNet